Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Analogs”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableEnrolling By InvitationNCT02270567
What this trial is testing

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

Who this might be right for
Neuroendocrine TumorCarcinoidNeuroendocrine Carcinoma
Wren Laboratories LLC 400
Post-approval studies (Phase 4)Study completedNCT00376064
What this trial is testing

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT01188733
What this trial is testing

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionEsophageal Varices
Mayo Clinic 39
Testing effectiveness (Phase 2)Study completedNCT02795858
What this trial is testing

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Who this might be right for
Carcinoid Tumors
Dana-Farber Cancer Institute 43
Post-approval studies (Phase 4)Study completedNCT03289741
What this trial is testing

Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Who this might be right for
Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center 51
Not applicableStudy completedNCT02152124
What this trial is testing

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Who this might be right for
Acromegaly
University Hospital, Ghent 21
Testing effectiveness (Phase 2)Ended earlyNCT07037420
What this trial is testing

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Who this might be right for
Acromegaly
Alexion Pharmaceuticals, Inc. 8
Large-scale testing (Phase 3)Looking for participantsNCT06930625
What this trial is testing

Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Who this might be right for
Acromegaly
Debiopharm International SA 119
Not applicableActive Not RecruitingNCT07534371
What this trial is testing

Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study

Who this might be right for
Neuroendocrine Tumors
West China Hospital 500
Not applicableStudy completedNCT00500227
What this trial is testing

Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery

Who this might be right for
Acromegaly
Ipsen 55
Not applicableUnknownNCT03812939
What this trial is testing

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Who this might be right for
Gastric NET
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06456359
What this trial is testing

Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell TumorSynovial Sarcoma
University Hospital Heidelberg 28
Testing effectiveness (Phase 2)Ended earlyNCT02489604
What this trial is testing

Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Large-scale testing (Phase 3)UnknownNCT02705651
What this trial is testing

Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment

Who this might be right for
Pancreatic Neuroendocrine Tumors in MEN1
Medical University of Vienna 180
Large-scale testing (Phase 3)Study completedNCT00447499
What this trial is testing

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Who this might be right for
Acromegaly
Ipsen 59
Large-scale testing (Phase 3)Study completedNCT01620138
What this trial is testing

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Who this might be right for
Non-functioning Pituitary AdenomasProlactinomas
Universidade Federal do Rio de Janeiro 21
Testing effectiveness (Phase 2)Ended earlyNCT02859064
What this trial is testing

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Who this might be right for
Neuroendocrine TumorsGastrointestinal NeoplasmsCarcinoid Tumors
SCRI Development Innovations, LLC 6
Early research (Phase 1)UnknownNCT03774680
What this trial is testing

Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer

Who this might be right for
Colon CancerColo-rectal Cancer
Ahmed A. H. Abdellatif 30
Large-scale testing (Phase 3)Study completedNCT00600886
What this trial is testing

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 358
Testing effectiveness (Phase 2)Study completedNCT03789656
What this trial is testing

Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)

Who this might be right for
Acromegaly
Crinetics Pharmaceuticals Inc. 47
Next Page